ClinicalTrials.Veeva

Menu

Dutch Version Fear-Avoidance Component Scale (FACS)

H

Hasselt University

Status

Completed

Conditions

Musculoskeletal Pain
Shoulder Pain
Musculoskeletal Pain Disorder
Fear of Pain
Low Back Pain, Recurrent
Knee Pain Chronic
Hip Pain Chronic
Neck Pain
PROMs
Fear of Injury

Treatments

Diagnostic Test: Assessment of disability and behavior (by questionnaires)

Study type

Interventional

Funder types

Other

Identifiers

NCT03994861
18.61/REVA18.02

Details and patient eligibility

About

Chronic musculoskeletal disorders such as low back and neck pain are responsible for an enormous global burden. Fear-avoidance (FA) can be a predictor for the transition from subacute to chronic low back pain. In patients with neck pain, those who were less fearful about harming their neck, had higher pain tolerance, which might have a positive impact on their level of disability. A new scale, the Fear-Avoidance Component Scale (FACS) was developed by Neblett, Mayer, Hartzell, Williams and Gatchel (2015) to assess FA. It consists of an all-encompassing set of constructs that more effectively deals with all critical issues of the FA concept than current scales do. Current scales have been criticized because of following findings: limited construct validity, little evidence on treatment responsiveness, a lack of evidence-based cut-off scores and items being too narrow or too general. The new scale comprehensively assesses all cognitive, emotional and behavioral components related to the updated version of the FA model by combining items of well-known scales in context of the FA model with items on one's perception of victimization and blame related to an injury. A Dutch version of the FACS is currently lacking. Subsequently, the aim of this study is to investigate different psychometric properties of the generated Dutch version in patients with musculoskeletal disorders.

Enrollment

100 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria for all patients

  • between 18-80 years old
  • current pain complaint is not surgically treated
  • not being currently treated by a physiotherapist for pain complaint
  • Dutch language is mother tongue
  • At least 6 weeks of pain Exclusion criteria for all patients
  • Pain from a non-musculoskeletal origin (e.g., tumour)
  • neurological disease
  • impaired cognition Inclusion criteria for healthy controls
  • Not being disabled due to MSK pain based on cut-off per disability questionnaire
  • Between 18-80 years old
  • Dutch language is mother tongue

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Patients with musculoskeletal disorders
Active Comparator group
Description:
Patients with either shoulder pain, knee pain, hip pain, low back pain, pelvic pain or neck pain as their primary pain complaint, lasting for 6 weeks or longer
Treatment:
Diagnostic Test: Assessment of disability and behavior (by questionnaires)
Healthy controls
Sham Comparator group
Description:
Age- and gender-matched healthy controls (without musculoskeletal pain)
Treatment:
Diagnostic Test: Assessment of disability and behavior (by questionnaires)

Trial contacts and locations

1

Loading...

Central trial contact

Liesbet De Baets, PhD, PT; Lotte Janssens, PhD, PT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems